Pharmacy compliance director pleads guilty over mislabeled drugs

The former director of compliance for a compounding pharmacy company pleaded guilty last week to introducing adulterated drugs into interstate commerce and conspiracy to defraud the United States by obstructing the Food and Drug Administration’s lawful functions.

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.